Effectiveness, efficiency, and NICE
- PMID: 11312215
- PMCID: PMC1120120
- DOI: 10.1136/bmj.322.7292.943
Effectiveness, efficiency, and NICE
References
-
- National Institute for Clinical Excellence. Appraisal of new and existing technologies: interim guidance for manufacturers and sponsors. London: NICE; 1999. www.nice.org.uk/nice-web/Embcat.asp?page=oldsite/appraisals/apr_gide.htm (accessed 19 March 2001).
-
- National Institute for Clinical Excellence. Zanamivir (Relenza) guidance from NICE. 12 October 1999. www.nice.org.uk/nice-web/Article.asp?a=427&c=153 (accessed 19 March 2001).
-
- National Institute for Clinical Excellence. Use of Zanamivir (Relenza) in the treatment of influenza. http://www.nice.org.uk/pdf/NiceZANAMIVAR15guidance.pdf (accessed 19 March 2001).
-
- Commonwealth of Australia. Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee: including major submissions involving economic analyses. Canberra: Australian Government Publishing Service; 1995.
-
- Ministry of Health. Ontario guidelines for economic analysis of pharmaceutical products. Ontario: Ministry of Health; 1994.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources